| 发明名称 |
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER |
| 摘要 |
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof. |
| 申请公布号 |
SG10201609772P(A) |
申请公布日期 |
2017.01.27 |
| 申请号 |
SG10201609772P |
申请日期 |
2013.05.21 |
| 申请人 |
GANYMED PHARMACEUTICALS AG;TRON - TRANSLATIONALE ONKOLOGIE AN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GEMEINNÜTZIGE GMBH |
发明人 |
SAHIN, UGUR;TÜRECI, ÖZLEM;MITNACHT-KRAUS, RITA;JACOBS, STEFAN DENIS;UTSCH, MAGDALENA JADWIGA;HEINZ, CORNELIA, ADRIANA, MARIA;STADLER, CHRISTIANE REGINA |
| 分类号 |
|
主分类号 |
|
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
